{"disease":{"id":"akathisia-drug-induced","name":"akathisia drug induced"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00693472","title":"Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":46,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00686699","title":"Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}